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The discovery of microRNAs (miRNAs) has led to a paradigm shift in our basic
understanding of gene regulation. Competing endogenous RNAs (ceRNAs) are the recent
entrants adding to the complexities of miRNA mediated gene regulation. ceRNAs are
RNAs that share miRNA recognition elements (MREs) thereby regulating each other. It
is apparent that miRNAs act as rheostats that fine-tune gene expression and maintain
the functional balance of various gene networks. Thus MREs in coding and non-coding
transcripts have evolved to become the crosstalk hubs of gene interactions, affecting
the expression levels and activities of different ceRNAs. Decoding the crosstalk between
MREs mediated by ceRNAs is critical to delineate the intricacies in gene regulation, and
we have just begun to unravel this complexity.
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INTRODUCTION
In recent years, advances in genomic sequencing have led to sev-
eral discoveries that can be considered exceptions to the central
dogma of molecular biology. Much of the DNA that does not
encode proteins has been shown to code for various types of
functional RNAs that have important regulatory roles. The com-
plexities in gene regulation increased logarithmically following
the identification of microRNAs (miRNAs). miRNAs are 18–22
nucleotide long, evolutionarily conserved single-stranded RNA
molecules that play a significant role in maintaining cellular iden-
tity and homeostasis (Bartel, 2004). miRNA mediated regulatory
networks were identified as drivers in diverse disease conditions
including cancers, where they function either as oncogenes or
as tumor suppressors (Hofacker, 2007; Kapsimali et al., 2007;
Moffett and Novina, 2007; Croce, 2009). This was followed by the
discovery of several non-coding RNAs with regulatory functions
in disease conditions (Rinn et al., 2007; Clark and Mattick, 2011;
Sun et al., 2013). Several studies have demonstrated the com-
plex mechanisms by which miRNAs regulate gene expression by
interacting with multiple networks (Hammond, 2007; Yang et al.,
2007; Sarver et al., 2010). This is because a single miRNA can reg-
ulate tens or hundreds of mRNA targets and, conversely, several
miRNAs can regulate a single mRNA (Eulalio et al., 2008; Bartel,
2009; Friedman et al., 2009; Ebert and Sharp, 2012). Depending
on the degree of homology of the seed sequence (6–8 nucleotide
long miRNA region that determines target specificity), miRNAs
can either completely degrade the target mRNAs (perfect base
Abbreviations: ceRNA, competing endogenous RNAs; ciRs, circular RNAs; lncR-
NAs, long non-coding RNAs; miRNA, microRNA; MREs, microRNA recognition
elements; UTRs, Untranslated region.
pairing) or act as road-blocks to translation (imperfect base pair-
ing) (Yekta et al., 2004; Eulalio et al., 2008; Bartel, 2009). The
multifaceted role of miRNAs can be appreciated by the recently
described decoy activity of miRNAs, signaling a paradigm shift.
Perrotti’s group observed that in leukemic blasts, miR-328 is
downregulated in a BCR/ABL-dependent manner (Eiring et al.,
2010). In these cells, there is increased expression of the RNA
binding protein hnRNP E2, which interacts with mRNA for a
transcription factor CEBPA, inhibiting its translation. miR-328
functions as a decoy by competing with CEBPA mRNA for the
hnRNP E2 binding site, thereby preventing the translational inhi-
bition of CEBPA mRNA. This function is in addition to its
canonical function of suppressing PIM1 protein kinase transla-
tion, but nonetheless is critical to the regulatory control of the
blast cell oncogenesis.
Gene expression can be regulated in cis by enhancer sequences
or in trans by genes that encode transcription factors (that act
as activators or repressors) or RNA binding proteins. Recently,
several studies have demonstrated that both coding and non-
coding RNA molecules can regulate gene expression in trans by
acting as sponges of miRNAs (Karreth et al., 2011; Salmena et al.,
2011; Tay et al., 2011; Karreth and Pandolfi, 2013; Su et al., 2013).
Together these RNAmolecules are called “competing endogenous
RNAs” (ceRNAs), which constitute a major proportion of gene
regulators. The identification of this level of gene regulation
can explain the correlation between genome size and increase
in species complexities. Although the number of protein-coding
genes is comparable between lower organisms and humans, there
is a proportional increase between the number of non-coding
transcripts and the complexity among species (Mattick, 2011a,b).
These ceRNAs share sequences recognized by the miRNAs called
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microRNA recognition elements (MREs). The ratio of noncoding
to coding sequences in humans is about 47:1 (Frith et al., 2005)
with up to 97% of the human genome constituting non protein-
coding DNA (Tisseur et al., 2011). Further discovery of this
additional layer of complexity in gene regulatory networks opens
up new avenues for targeting therapy. The ceRNA concept, which
describes the cross talk between RNA molecules mediated by
miRNA recognition elements (MREs), is illustrated in Figure 1.
miRNA SPONGES: A HISTORICAL PERSPECTIVE
miRNAs regulate their target genes by binding to complementary
sequences in the 3′ UTR. In order to understand the function
of these miRNAs in biological systems, a general approach is to
design miRNA sponges or target mimics that harbor several bind-
ing sites for a miRNA of interest. This concept of competitive
target inhibition of miRNAs within a cell was first demonstrated
by Phil Sharp’s laboratory (Ebert et al., 2007). By this approach,
one can decrease the number of miRNAs that are available to
interact with an mRNA of interest, thus generating a loss-of-
function phenotype in cell culture. At the same time, miRNA
sponges were also observed to occur naturally.
The first endogenous miRNA sponge was discovered in plants
and was found to moderate a miRNA mediated response to envi-
ronmental stress (Franco-Zorrilla et al., 2007). The identified
sponge was a non-coding RNA, Induced by Phosphate Starvation
1 (IPS1) with a binding site for miR-399, a phosphate starvation-
induced miRNA. However, miR-399 binding does not induce
degradation of the IPS1 transcript due to mismatched nucleotides
FIGURE 1 | Schematic representation of ceRNAs mediated gene
regulation. The regulation of miRNAs and mRNAs are mutual; as a
consequence, levels of mRNA(s) containing relevant MREs could affect the
levels and activity of another mRNA. The cross talk between mRNAs
mediated by the MREs depends on the number and frequency of specific
type of MREs. This cross talk is significantly influenced by the number and
frequency of relevant MREs in the transcriptome of a given cell. The
ceRNA-miRNA-mRNA cross talk maintains the overall activity and
functional balance of gene networks in a cell. The ceRNA mediated
regulation of mRNA-Y is illustrated here. mRNA-Y is a functional target of
miR-B. However, the expression levels of mRNA-X that contains MREs for
miRNA-B can act like a sponge to sequester the effect of miR-B on
mRNA-Y (indicated with bold red line). Hence a decrease in expression
levels of mRNA-X can also decrease the levels of mRNA-Y.
in the binding site, but rather results in sequestration of miR-399
from other target transcripts. Thus, IPS1 can effectively function
as a sponge inhibiting the number of miR-399molecules available
for regulating its target PHO2 mRNA. The Arabidopsis thaliana
pho2mutant is a phosphate over-accumulator. Thismutant carries
a mutation in the PHO2 gene, encoding a ubiquitin-conjugating
enzyme (UBC24), that leads to a reduction in full-length tran-
scripts. (Aung et al., 2006; Lin et al., 2008). This mutation causes
symptoms related to inorganic phosphate (Pi) toxicity, as a con-
sequence of enhanced Pi uptake, facilitated translocation of Pi
from roots to shoots and impaired Pi remobilization from old to
your leaves (Bari et al., 2006; Chitwood and Timmermans, 2007).
Initially during phosphate starvation, PHO2 is downregulated
(Bari et al., 2006; Chitwood and Timmermans, 2007). In response
to phosphate starvation, IPS1 RNAs are induced. The latter can
sequestermiR-399resulting instabilizationand increasedaccumu-
lation of PHO2 and, concomitantly, in reduced shoot phosphate
content (Franco-Zorrilla et al., 2007). The authors coined the
term “target mimicry” to define this mechanism of inhibition of
miRNA activity.
This idea of target mimicry demonstrates unanticipated com-
plexity in the network of RNA regulatory interactions and was the
first natural example of self-regulation by RNAs. Subsequently,
target mimicry has been exploited to determine the function
of plant miRNA families using a high-throughput approach to
generate a large-scale collection of knockdowns for Arabidopsis
thaliana miRNA families (Todesco et al., 2010). This idea was fol-
lowed by the discovery of several mRNAs that can competitively
inhibit regulatory small RNAs in prokaryotes (Figueroa-Bossi
et al., 2009;Mandin andGottesman, 2009; Overgaard et al., 2009).
In marmoset T cells transformed with primate virus Herpesvirus
saimiri (HSV), downregulation of host miRNAs miR-16, -27, and
-142-3p by viral non-coding transcripts called HSURs (H.saimiri
U-rich RNAs) was observed (Cazalla et al., 2010). Additionally,
protein expression of themiR-27 target gene FOXO1was observed
to be upregulated in the presence ofHSUR1, although neither the
cellular compartment in which this interaction between HSUR
and miRNA occurs nor the mechanism by which HSUR induces
miRNA regulation are understood (Ebert and Sharp, 2010).
Recently, sponge activity of viral RNA was confirmed by infection
of mouse cells with murine cytomegalovirus resulting in rapid
downregulation of anti-viral cellular miR-27 (Libri et al., 2012;
Marcinowski et al., 2012). The authors in this study speculate
that RNA mediated miRNA degradation could be a more general
strategy employed by viruses to manipulate host cells. Another
example for miRNA sponge activity in cancer progression is that
of a non-coding RNA called “highly upregulated in liver cancer”
(HULC), one of the most up regulated of all genes in hepatocel-
lular carcinoma (Panzitt et al., 2007). Subsequently, Wang et al.
documented that CREB (cAMP reponse element binding) protein
is involved in upregulation of HULC and that HULC sequesters
several miRNAs including miR-372, leading to derepression of its
target protein, PRKACB, which in turn induces phosphorylation
and activation of CREB (Wang et al., 2010). Thus HULC is an
autoregulatory long non-coding RNA.
In spite of these observations of the occurrence of competitive
inhibition, it was not until 2009 that a wider biological function
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was proposed for this regulatory mechanism. Following the
discovery of natural miRNA sponges it was speculated that these
regulatory RNAs exist to maintain periodicity in gene expression,
by allowing brief spurts of miRNA activity followed by a pause
during which time target mRNA levels can recover (Chitwood
and Timmermans, 2007). Further, Seitz observed three paradoxes
with respect tomiRNAmediated gene regulation: (1) miRNA reg-
ulates several gene targets, yet the repression of only a few target
genes significantly affects physiological function; (2) the extent
of miRNA-mediated repression is remarkably lower as compared
to endogenous genetic variations, which are well-tolerated; and
(3) miRNA gene targets are significantly conserved among related
species, but vary greatly between more distant species (Seitz,
2009). Seitz proposed that several of the computationally iden-
tified targets of miRNA can function as its competitive inhibitor,
sequestering that miRNA, thereby preventing it from binding to
its authentic mRNA target (Seitz, 2009). Seitz study postulates
that miRNAs bind not only to their legitimate targets, whose
activity is sensitive to small reduction in protein expression, but
also to its pseudotargets that, on the contrary, are insensitive to
such small reductions that can buffer and dilute miRNA activity.
This formed the basis for the ceRNA hypothesis (Salmena et al.,
2011), which was substantiated by the identification and charac-
terization of several novel categories of ceRNAs in mammalian
tissues. In the following section, we describe the various types of
ceRNAs and provide a review of the experimental and/or theoret-
ical evidences for their regulatory function. These studies demon-
strate the competition between RNA molecules containing same
MREs, leading to the sharp, rapid, and dynamic upregulation of
target mRNAs.
PROTEIN CODING RNAs as ceRNAs
A flurry of recent studies in mammalian cells and tissues demon-
strated the competition between protein coding targets of miR-
NAs (Cesana et al., 2011; Karreth et al., 2011; Sumazin et al.,
2011; Tay et al., 2011). These studies support a regulatory role
for mRNAs independent of their protein coding function. Tay
et al. tested the hypothesis that RNAs actively regulate each other
through competitive sequestration of miRNA binding (Tay et al.,
2011). The authors identified and validated several endogenous
protein-coding transcripts that regulate phosphatase and tensin
homolog (PTEN), using a combined computational and experi-
mental approach. PTEN is a tumor suppressor gene, mutations
in which have been implicated in several cancers. Further sub-
tle changes in PTEN dose can dictate critical outcomes with
respect to tumor initiation and progression (Trotman et al., 2003;
Alimonti et al., 2010; Berger et al., 2011). Thus identifying ceR-
NAs for PTEN is of functional significance. This combinatorial
analysis identified over 100 protein coding mRNAs that share
MREs with PTEN. Furthermore, the authors observed the com-
peting transcripts such as CNOT6L and VAPA to antagonize
PI3K/AKT signaling, thereby contributing to growth- and tumor-
suppressive properties. One additional PTEN ceRNA that has
been functionally validated is Zinc finger E-box-binding home-
obox 2 (ZEB2) (Karreth et al., 2011). Using Sleeping Beauty inser-
tional mutagenesis screen in a mouse model of melanoma, the
authors identified 33 putative PTEN ceRNAs. Further validation
was performed using RNAi-mediated gene silencing in human
melanoma cells. In this manner, silencing of 6 ceRNAs, including
ZEB2, showed significant attenuation in PTEN levels in amiRNA-
dependent, protein coding-independent manner. In addition to
the regulatory function of the ZEB2 transcript, its protein func-
tion is well established as a transcription factor. The ZEB2
transcription factor is an activator of epithelial-to-mesenchymal
transition (EMT) and thus it is oncogenic and involved in the pro-
gression of epithelial cancers (Vandewalle et al., 2005; Gregory
et al., 2008; Vandewalle et al., 2009). On the other hand, in this
study the authors show that reduction of ZEB2 mRNA expression
activates the PI3K/AKT pathway and enhances cell transforma-
tion. Reduction of ZEB2 mRNA expression commonly occurs in
humanmelanomas and other cancers expressing low PTEN levels.
Thus the mRNA and protein of ZEB2 have contradictory tumor
suppressive and oncogenic functions, respectively. However, in
light of a recent study showing that ZEB2 protein is oncosuppres-
sive in melanoma (Caramel et al., 2013), the functional role of
ZEB2 is context and tumor type dependent.
In a third study, large scale analysis of gene expression data
withmatchedmiRNA expression profiles in human glioblastomas
identified ∼7000 genes that can act as miRNA sponges or target
decoys (Sumazin et al., 2011). Further biochemical analyses in cell
lines demonstrated an intricate network regulating established
driver genes including PTEN, PDGFRA, RB1, VEGFA, STAT3,
and RUNX1, that allows cross talk between several canonical
oncogenic pathways by titrating the activity of commonmiRNAs.
Thus, although individual miRNAs contribute to small changes in
gene expression, the combinatorial effect of multiple ceRNAs that
interact via common MREs can be substantial and can explain
the gene regulatory process in situations where there are no direct
transcriptional or post-transcriptional interactions. While, MREs
in a given transcript can regulate their own levels (cis regulation at
transcript level) it can be noted that theseMREs can also influence
the levels and activity of other mRNAs (trans regulation) by com-
peting for the miRNAs. mRNA mediated cis and trans regulation
is schematically represented in Figure 2.
PSEUDOGENES as ceRNAs
The identification of a novel biological role for the expressed
pseudogene of PTEN was the first experimental proof for the
cross talk between coding and non-coding RNAs (Poliseno et al.,
2010). Poliseno et al. showed that in addition to protein-coding
FIGURE 2 | cis and trans regulation of mRNA. The MREs in the 3′UTR of
mRNA can act as cis regulatory elements affecting its own stability and
levels via miRNAs. On the other hand, MREs in the mRNAs functioning as
ceRNAs can regulate the levels and activity of another mRNA by trans
regulation.
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function, RNAs possess regulatory function and demonstrated
this using mRNAs produced by the PTEN tumor suppressor gene
and its pseudogene PTENP1 (also known as PTENpg1, PTEN2,
PTENψ1). They showed that MREs are conserved between PTEN
and PTENP1 and, as a consequence, overexpression of PTENP1
3′UTR correspondingly increased cellular levels of PTEN by
sequestering all miRNAs that inhibit PTEN. This in turn led to
growth inhibition. The authors also observed a direct correla-
tion between the expression of PTEN and PTENP1 in normal
human tissues and prostate tumor samples suggesting these to
be co-regulated. Further there was a direct relationship between
PTENP1 copy number and PTEN expression in colon cancer
tissues, indicating that PTENP1 transcript levels can regulate
PTEN expression and thus act as a tumor suppressor (Poliseno
et al., 2010). A similar observation was also reported in this
study for KRAS gene: KRAS1P pseudogene pairs. The tran-
script levels of KRAS and KRAS1P were positively correlated
in prostate cancer tissues. Interestingly, amplification of the
KRAS1P locus is reported for several human tumors, including
neuroblastoma, retinoblastoma, and hepatocellular carcinoma
(Plantaz et al., 1997; Zimonjic et al., 1999; Van Der Wal et al.,
2003). These observations indicate a proto-oncogenic role for
KRAS1P.
Supporting the regulatory function of pseudogenes, Poliseno
et al. also reported conservation in the MREs of specific miR-
NAs between a gene and its pseudogene, in the majority of
the genes analyzed. For instance, OCT4 pseudogenes OCT4-
pg1, 3, 4, and 5 maintained validated binding sites for miR-
145, CDK4 pseudogene CDK4PS for miR-34 family, FOXO3
pseudogene FOXO3B for miR-182, KRAS pseudogene KRAS1P
maintained MREs for miR-143 and let-7 family, while E2F3
pseudogene E2F3P1 maintained validated binding sites for miR-
17 family but not for miR-34 family. DNMT3A pseudogene
DNMT3AP1 did not maintain MREs for miR-29 family and
miR-143. Thus it seems that the function of a pseudogene gen-
erally mirrors its kindred gene function and contributes to a
miRNA decoy mechanism (Poliseno et al., 2010). Pseudogenes
can possess many of the same MREs that are harbored on the
ancestral genes and thus act as perfect sponges (Salmena et al.,
2011). It is noteworthy that many ribosomal genes have several
pseudogenes that are differentially regulated (Balasubramanian
et al., 2009), indicating intricately dynamic mechanisms for RNA
cross talk.
Recently Johnsson et al. reported a hitherto unknown mech-
anism of regulation of PTEN transcription and translation by
pseudogenes (Johnsson et al., 2013). The authors identified and
characterized two antisense RNA (asRNA) isoforms, α and β
which are encoded by pseudogene, PTENP1, in addition to the
sense transcript that was shown to act as a miRNA sponge.
The asRNA was generally expressed at higher copy numbers as
compared to their sense counterpart (Johnsson et al., 2013).
The α isoform of asRNA, acting in trans was shown to nega-
tively regulate PTEN transcription by recruiting repressive chro-
matin remodelers, DNA methyltransferase 3A (DNMT3a) and
Enhancer of Zeste (EZH2) to PTEN promoter region and cat-
alyzes the formation of H3K27me3 chromatin mark (Johnsson
et al., 2013). The isoform β, on the other hand, regulated PTEN
at the post-transcriptional level. The β asRNA isoform interacted
with the PTENP1sense transcript in the cytoplasm maintaining
its stability, thereby affecting the sense miRNA sponge activ-
ity. This study is an elegant example of the intricate regulatory
network involving pseudogenes and coding RNAs.
Another pseudogene acting as a miRNA sponge is OCT4-pg4,
which is abnormally activated in hepatocellular carcinoma (Wang
et al., 2013a). OCT4 is a POU transcription factor which is a
pleiotropic regulator of gene expression in embryonic stem cells.
The authors demonstrate that this pseudogene can protect OCT4
transcripts from miR-145 inhibition, thereby upregulating its
protein expression. Further a significant correlation was observed
between high OCT4-pg4 levels and poor prognosis, thus indicat-
ing this pseudogene to exert an oncogenic role in hepatocellular
carcinoma.
LONG NONCODING RNAs (lncRNAs) as ceRNAs
Any expressed RNA that is more than 200 nt in length and
lacks obvious protein coding capacity is considered a lncRNA
(Ponting et al., 2009). The dysregulation of lncRNAs has increas-
ingly been linked to many human diseases, including cancers
(Shi et al., 2013). The important roles played by lncRNAs in
brain development, neuron function and maintenance, and neu-
rodegenerative diseases are also becoming increasingly evident
(Wu et al., 2013). Specific lncRNAs function to regulate gene
expression either through epigenetic mechanisms or by post-
transcriptional events such as mRNA processing and degra-
dation by interacting with splicing factors and 3′ UTR ele-
ments, respectively (Guttman et al., 2009; Khalil et al., 2009;
Huarte et al., 2010). Examples of lncRNAs involved in epige-
netic regulation include X-inactive specific transcript (XIST) and
large intergenic noncoding RNAs (lincRNAs). Notably, recent
global analysis of Argonaute (Ago) bound transcripts through
high-throughput sequencing of RNAs isolated by crosslinking
immunoprecipitation (HITS-CLIP) technique suggests miRNA
mediated regulation of lncRNAs (Licatalosi et al., 2008; Chi et al.,
2009).
The ability of lncRNAs to function as ceRNA was first demon-
strated inmuscle differentiation (Cesana et al., 2011). The authors
identified a muscle-specific lncRNA, linc-MD1, which governs
the time of muscle differentiation by acting as a ceRNA in mouse
and human myoblasts. This lncRNA sequestered miRNAs, miR-
133 and miR-135 that specifically target protein coding genes
MAML1 and MEF2C, needed to activate the differentiation pro-
gram. Recently lincRNAs have also been shown to function as
a miRNA sponge in human embryonic stem cell self-renewal
(Cheng and Lin, 2013). Wang et al. showed that linc-RoR (reg-
ulator of reprogramming) functions as a miRNA sponge to post-
transcriptionally regulate mRNAs of the core transcription factors
for maintaining embryonic stem cell pluripotency (Wang et al.,
2013b). Linc-RoR competes withmRNAs forOCT4, NANOG and
SOX2 formiR-145 binding. Consistent with its sponge effect, linc-
RoR copy number was observed to be much higher than that of
miR-145 (>100 vs. 10–20 copies/cell) in self-renewing embry-
onic stem cells compared to differentiating embryonic stem cells
(20 vs. >500 copies/cell). Thus the sponge effect of linc-RoR can
disappear once the embryonic stem cells start to differentiate.
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CIRCULAR RNAs (circRNAs or ciRs) FUNCTION as ceRNAs
Occasionally RNAs that are covalently linked at the ends to form
circular molecules have been described in literature. circRNAs
were discovered in plants and were shown to be derived from
viroids (Sanger et al., 1976). In lower organisms, circRNAs stem
from self-splicing introns of pre-ribosomal RNA (Grabowski
et al., 1981). In animals, many circRNAs overlap with the cod-
ing genes and arise from head-to-tail splicing of one or more
exons. The best-known circRNA in animals is the antisense to the
mRNA transcribed from SRY (sex-determining region Y) locus
and considered circular testis-determining RNA (Capel et al.,
1993). Nevertheless, circRNAs were considered rare until recently
when several groups demonstrated their widespread occurrence
within transcriptomes (Salzman et al., 2012; Wu et al., 2012; Jeck
et al., 2013). It was only very recently that a ceRNA function was
attributed to this highly prevalent class of conserved regulatory
RNA molecules (Hansen et al., 2013; Memczak et al., 2013).
Memczak et al. adopted a novel computational methodology
to screen RNA-seq libraries and detected thousands of human,
mouse and C. elegans circRNA candidates (Memczak et al., 2013).
They observed sequence conservation in these circRNAs and
found several of these molecules to be specifically expressed in
a cell type or developmental stage. Thus the authors speculated
these previously disregarded molecules to perform a biological
function, possibly in mediating gene regulation. Their hypothesis
was proved by the characterization of a human circRNA, anti-
sense to the cerebellar degeneration-related protein 1 transcript
(CDR1as) also known as ciRS-7 (Hansen et al., 2013; Memczak
et al., 2013). This brain-enriched circRNA harbors>70MREs for
the ancient miR-7 and forms complexes with Argonaute (AGO)
protein in a miR-7 dependent manner. CDR1as (ciRS-7) is co-
expressed with miR-7 in the brain and is co-localized in the
P-bodies indicating that miR-7 compartmentalizes this circRNA
to this organelle (Hansen et al., 2013). Further using functional
approaches, it was demonstrated that the main role of CDR1as
ciRS-7 is to bindmiR-7 in neuronal tissues and ectopic expression
of CDR1 is associated with morphological defects in the mid-
brain, phenocopying miR-7 knock-down (Hansen et al., 2013;
Memczak et al., 2013).
It is noteworthy that non-coding RNAs, including pseudo-
genes, lncRNAs, and circRNAs behave more effectively as ceRNAs
than do protein-coding RNAs since non-coding RNAs are not
involved in the active protein translation process (Gu et al.,
2009). While the miRNA sponges or miRNA-competing tran-
scripts (protein-coding RNAs, pseudogenes, and lncRNAs) are
expressed at low levels, contain a limited number of MREs, and
are themselves subject to miRNA-mediated destabilization, cir-
cRNAs have been shown to be long-lived in vivo compared to
their linear counterparts and are completely resistant to miRNA-
mediated target destabilization (Hansen et al., 2013; Memczak
et al., 2013). A recent study also showed that circRNAs can be
used as “next generation” exogenous sponges that outperform
linear ones (Liu et al., 2013a). Circular miRNA sponges against
miR-21 or miR-221 obtained using the self-splicing permuted
intron-exon sequences derived from T4 bacteriophage gene td
(Liu et al., 2013b) were introduced into malignant melanoma
cell lines and resulted in excellent anti-cancer effects. In sum,
FIGURE 3 | Interactions between different types of ceRNAs, miRNA,
and mRNA. Coding RNAs and non-coding RNAs including pseudogenes,
lncRNAs, and circular RNAs can function as ceRNAs.
the non-coding RNAs vast outnumber the protein coding genes
and are extremely versatile in their mechanism of action (Djebali
et al., 2012; Guttman and Rinn, 2012). A schematic representation
of various types of ceRNAs and their unifying role in tweaking
mRNA expression level and activity is provided in Figure 3.
IDENTIFICATION OF ceRNAs
COMPUTATIONAL METHODS
The knowledge of precise numbers, types, and positions of MREs
are very important for identification of ceRNAs. Although sev-
eral target prediction algorithms are available, many are not
successful in identifying all the important targets as the criteria
for identifying targets are still evolving (Bartel, 2009). Tay et al.
developed an approach termed mutually targeted MRE enrich-
ment (MuTaME), involving integrated computational analysis
and experimental validation (Tay et al., 2011). The authors used
Rna22 miRNA target prediction algorithm (Miranda et al., 2006)
to generate the MuTaME scores for the protein coding transcripts
in humans. The MuTaME program evaluates a potential ceRNA
based on (a) the number of miRNAs that are shared between
transcripts of interest, (b) the number of predicted MREs in the
transcript for a particular miRNA and the sequence span in which
they are represented, (c) the distribution of the MREs of a partic-
ular miRNA on the transcript and (d) the relation between the
total numbers of MREs predicted in a transcript to the total num-
ber of miRNAs that recognize these MREs. Using the MuTaME
prediction algorithm Tay et al. (2011) demonstrated the phys-
ical association of PTEN-targeting miRNAs with PTEN ceRNA
CNOT6L.
In order to assess the range and potential of miRNA-mediated
regulatory interactions with a tumorigenic role, a novel multi-
variate analysis method called Hermes was developed (Sumazin
et al., 2011). Hermes uses a large collection of mRNA and
miRNA expression profiles obtained from same tumor samples
to identify modulators of miRNA activity. Further, in order to
predict the ceRNA network, the HERMES algorithm also consid-
ers non-coding RNAs. The program uses mutual and conditional
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mutual information to quantify the dependency of one variable
over the other variable, which in this case is affected by poten-
tial ceRNAs. Using this program, the authors were able to predict
the sponge interactions among ceRNAs in a glioblastoma dataset
(Sumazin et al., 2011).
Our group subsequently developed a database named “com-
peting endogenous RNA database” (ceRDB) that can help identify
ceRNAs for a given mRNA. The program examines the co-
occurrence of MREs in the mRNAs (3′ UTRs) on a genome-wide
basis to predict ceRNAs for a specific mRNA targeted by miR-
NAs (Sarver and Subramanian, 2012). The ceRNA finder database
is available through www.oncomir.umn.edu/cefinder. The pro-
gram uses over 50,000 conserved human miRNA-mRNA target
interactions obtained from Targetscan predictions with a matrix
containing 153miRNA families and 9448 target mRNAs. For each
mRNA, the interactions are scored based on the sum of the total
number of miRNA binding sites for a given miRNA. The interac-
tion scores based on the MRE frequency is sorted to predict the
top 50 potential ceRNAs for a gene of interest.
More recently amathematical mass-actionmodel to determine
the optimal conditions for ceRNA activity in vivowas described by
Pandolfi’s group (Ala et al., 2013). The program mathematically
models the complex network environment in which ceRNAs can
function with optimal activity. Furthermore, the authors found
that ceRNAs are responsive to modulations in the levels of various
transcription factors. Thus, the deregulation of one ceRNA can
have dramatic effect on the integrated ceRNA and transcriptional
network. Besides the mass-action model there are also several
other model systems reported (Bosia et al., 2013; De Giorgio et al.,
2013; Figliuzzi et al., 2013; Noorbakhsh et al., 2013). Linc2GO,
a lincRNA (long intergenic non-coding RNA) function annota-
tion database was recently generated to predict lincRNA functions
based on ceRNA hypothesis (Liu et al., 2013a).
The critical aspects of ceRNA identification are co-expression
of the ceRNA, expression of miRNAs that commonly target the
ceRNAs and the physical association (in part determined by the
binding site availability due to RNA secondary structures) of miR-
NAs with the ceRNAs. Although various miRNA target prediction
programs use algorithms to include seed sequence matches, evo-
lutionary conservation of binding sites, and flanking secondary
structures (Bartel, 2009), they predominantly focus on the 3′UTR
regions to predict the physical association between miRNAs and
target genes. Based on the recent findings that pseudogenes, lncR-
NAs and circular RNAs, can potentially function as ceRNAs, it
becomes difficult to precisely determine the complete spectrum of
all ceRNAs for a given gene of interest, unless non-coding RNAs
are included in the target prediction algorithms.
EXPERIMENTAL METHODS
Several biochemical techniques have also enabled the exper-
imental identification and functional validation of ceRNAs.
For instance, Argonaute high-throughput sequencing of RNAs
isolated by crosslinking immunoprecipitation (Ago HITS-
CLIP), photoactivatable-ribonucleoside-enhanced crosslinking
and immunoprecipitation (PAR-CLIP) and RNA immunopre-
cipitation are some platforms that, by providing a footprint of
all the miRNAs physically bound to a given RNA, can enable
identification of MREs and will provide insights on ceRNA reg-
ulatory networks (Thomas et al., 2010).
ceRNAs: WHAT NEXT?
It is becoming increasingly evident that regulation of gene expres-
sion through competition for miRNA binding is a general phe-
nomenon. The understanding of gene regulation at this com-
plexity has provided a functional explanation on how certain
previously known genes with no direct interactions are inter-
linked, as exemplified in the studies involving PTEN. But still,
there is more to be unraveled and learned.
It is evident that the relative production and turnover rates of
miRNAs, their target RNAs and ceRNAs can dictate the extent and
duration of gene regulation (Arvey et al., 2010; Ala et al., 2013).
There should be significant changes in ceRNA expression in order
to relieve the miRNA repression of target mRNAs. Similarly, the
magnitude of expression of the sequestered miRNAs should not
be very low or abundant, as both conditions can obliterate the
competition. Another factor that contributes to efficient compe-
tition is the number of miRNAs that a ceRNA can sponge. This
in turn depends on the subcellular distribution and interaction
of ceRNAs with RNA-binding proteins and ribosomes. Both ceR-
NAs and miRNAs should occur in the same tissue or cell type
or cellular compartment at a specific time. Yet another factor that
needs to be kept in mind is that not all MREs on ceRNAs are equal
when it comes to binding a specific miRNA. This will depend on
the nucleotide composition of MREs. All these details need to be
clearly worked out to better appreciate the role of ceRNAs.
Another potential area for future research is in understanding
the role of ceRNAs in disease pathophysiology. Several stud-
ies have analyzed gene or miRNA expression profiles in disease
conditions. With the emergence of ceRNA mechanisms, what is
warranted is a comprehensive analysis of both gene and miRNA
expression in the same pathological sample. This will allow for
identification of novel pathways that are deregulated in disease
condition and decipher novel interactions between relevant sig-
naling pathways. The bioinformatics tools that have been devel-
oped in recent years can contribute largely to this amount of
global analyses.
Additionally, disease characterization in general involves
extensive sequence analysis of coding regions to identify novel
disease-causing mutations. These can be due to deletions, ampli-
fications or chromosomal translocations as evident in cancer.
With the emergence of ceRNAs, the search for perturbations
should go beyond coding regions to include UTRs and introns
as these can cause changes in MREs, which in turn can affect
the complex regulatory circuits. For instance, gross genomic loss
and amplification can have dramatic consequences for ceRNAs
present in the region (Salmena et al., 2011). Similarly, chromo-
somal translocations can lead to UTR swaps (Stephens et al.,
2009). Aberrant alternative splicing and alternative cleavage and
polyadenylation events leading to shortening of 3′UTRs is another
common mechanism in cancer (Mayr and Bartel, 2009).
In addition to massive genomic rearrangements, point muta-
tions can lead to genetic disorders as observed with inborn errors
of metabolism. It is important to note that even though point
mutations abolish protein function, the mutant transcripts retain
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complete ceRNA function. Alternatively, point mutations in the
MREs can abolish potential ceRNA functions, thereby perturbing
the network. Sometimes these mutations are often overlooked,
since they are not part of the functional protein coding sequence.
Thus it is increasingly becoming important to have a whole
genome approach when it comes to understanding disease. Often
there is no correlation between the phenotype and genotype,
suggesting genetic modifiers to contribute to the disease. With
increasing evidence for miRNA mediated cross-talk, ceRNAs of
a given disease-causing gene can potentially act as the modifier.
MRE mediated cross-talk between transcripts is expected to
change our approaches in understanding disease mechanisms.
For example, inmicroarray data analysis, traditionally only signif-
icant fold-changes are considered while interpreting gene expres-
sion patterns. Knowing that the number of MREs and its dis-
tribution can alter gene expression levels and its activity, even
an insignificant fold-change in large number of genes is rele-
vant and can considerably contribute a number of MREs that can
affect the balance and dynamics of miRNA-mRNA interactions,
which in turn affect cellular functions. Further, it is also possible
that the transcripts with longer 3′UTR may function as “master
MRE” containing genes and splice variants of these transcripts
can also affect cell function. Gene regulation mediated by ceR-
NAs can also impact targeted therapy and therapeutic response.
Since transcripts can independently function as ceRNAs, target-
ing their resulting proteins by small molecule inhibitors can in
turn affect downstream the transcripts stability and levels that
may contribute to undesirable side effects on treatment outcomes
by the protein inhibitors. Modulation of levels of ceRNAs may
be a strategic alternative to directly targeting a protein of inter-
est. Further complicating this scenario is the recent finding that
miRNAs can function as agents of intercellular communication
(Arroyo et al., 2011; Lou et al., 2012; Steer and Subramanian,
2012). It is noteworthy that exosomes, which recently gained a
lot of attention with regard to its ability to mediate intercellu-
lar communication (Mittelbrunn et al., 2011), may harbor both
miRNAs and ceRNAs. This suggests that the miRNA pool in a
cell is in constant flux, making it more challenging to understand
gene regulation. Hence, it is critical to understand the spatial and
temporal relationships between the relevant ceRNAs, mRNA, and
miRNAs.
CLOSING REMARKS
ceRNAs mediated gene regulation is an emerging area of investi-
gation that will significantly increase our understanding of disease
pathobiology, particularly cancer. In general, multiple genes and
signaling pathways are deregulated in cancer. Many of these
genes have a redundant function that obscures identification of
therapeutically relevant target genes. In addition, contradictory
functions of mRNAs (as ceRNA) and proteins of a gene further
challenge the identification of relevant target genes. The trans
regulations of ceRNAs add yet another layer of complexity to
gene regulation that needs to be carefully investigated for key
oncogenes and tumor suppressors implicated in various cancer
types.
Overall, the normal functioning of cells depends on the main-
tenance of balance between complex regulatory systems. This is
achieved by dynamic and fine adjustments and through the ability
to rapidly return to normal threshold levels when imbalances are
detected. If the system fails to balance beyond threshold levels,
the cells manifest a disease condition. The challenges we face is
in understanding how this balance is maintained in physiolog-
ical conditions and conversely, how it is altered in disease. The
recent ENCODE project results suggest that about 85% of the
human genome is transcribed, the majority of which are lncRNAs
(Djebali et al., 2012; Hangauer et al., 2013). With the recent dis-
covery of many novel small and long non-coding RNA types with
distinctive functions, we are just beginning a new chapter in gene
regulation and disease biology with more “unknown unknowns.”
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